| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Psoriasis
|
NIAMS
|
5R01AR050266-02
|
|
Genome-wide SNP association in psoriasis
|
BOWCOCK, ANNE
|
WASHINGTON UNIVERSITY
|
MO
|
$633,702
|
|
Psoriasis
|
NIAMS
|
5K23AR051125-05
|
|
Investigating the Risk of Lymphoma in Psoriasis Patients
|
GELFAND, JOEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$132,462
|
|
Psoriasis
|
NIAMS
|
5K23AR052404-03
|
|
Dendritic cells in psoriasis and effects of efalizumab
|
LOWES, MICHELLE
|
ROCKEFELLER UNIVERSITY
|
NY
|
$135,378
|
|
Psoriasis
|
NIAMS
|
5R01AR050511-05
|
|
Identification of Psoriatic Arthritis Genes in Major Histocompatibility Complex
|
ELDER, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$224,927
|
|
Psoriasis
|
NIAMS
|
5R01AR042742-14
|
|
Linkage Analysis of Familial Psoriasis
|
ELDER, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$478,783
|
|
Psoriasis
|
NIAMS
|
5R01AR040065-16
|
|
Immunopathogenesis of Psoriasis
|
NICKOLOFF, BRIAN
|
LOYOLA UNIVERSITY CHICAGO
|
IL
|
$374,204
|
|
Psoriasis
|
NIAMS
|
5R01AR051498-05
|
|
Psoriatic regulatory T cell dysfunction
|
COOPER, KEVIN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$323,436
|
|
Psoriasis
|
NIAMS
|
1R01AR056079-01
|
|
Nanospheres as Delivery Vehicles for Psoriasis Therapeutics
|
SHEIHET, LARISA
|
RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK
|
NJ
|
$318,534
|
|
Psoriasis
|
NIGMS
|
5R01GM076063-03
|
|
Alkoxypsoralens, Small Molecule Blockers of the Voltage-Gated Kv1.3 Channel
|
WULFF, HEIKE
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$255,640
|
|
Psoriasis
|
NIAMS
|
5R01AR054966-02
|
|
Combined analysis of gene expression and DNA variation in psoriasis
|
ELDER, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$632,351
|
|
Psoriasis
|
NIAMS
|
5R21AR054495-02
|
|
ROLE OF IL-23 IN PSORIASIS PATHOGENESIS
|
BLAUVELT, ANDREW
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$132,741
|
|
Psoriasis
|
NIAMS
|
1R43AR056165-01
|
|
Development of topical rapamycin as a novel treatment for skin disorders
|
KASPAR, ROGER
|
TRANSDERM, INC.
|
CA
|
$226,281
|
|
Psoriasis
|
NIAMS
|
5R01AR050100-04
|
|
Classical conditioning in Pharmacotherapy of Psoriasis
|
TAUSK, FRANCISCO
|
UNIVERSITY OF ROCHESTER
|
NY
|
$1
|
|
Psoriasis
|
NIAMS
|
5R01AR052889-03
|
|
Amphiregulin in Psoriatic Epidermal Hyperplasia
|
ELDER, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$286,388
|
|
Psoriasis
|
NIAMS
|
5R01AR047652-07
|
|
STRESS INDUCED SKIN MAST CELL ACTIVATION & VASODILATION
|
THEOHARIDES, THEOHARIS
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$346,602
|
|
Psoriasis
|
NCRR
|
1S10RR025090-01
|
|
Pulsed EPR Spectrometer
|
SPRINGER, TIMOTHY
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$952,390
|
|
Psoriasis
|
NIAMS
|
1F32AR056799-01
|
|
Risk of diabetes and poor diabetic control in psoriasis
|
AZFAR, RAHAT
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$51,278
|
|
Psoriasis
|
NIAMS
|
3R01AR050266-02S1
|
|
Genome-wide SNP association in psoriasis
|
BOWCOCK, ANNE
|
WASHINGTON UNIVERSITY
|
MO
|
$76,000
|
|
Psoriasis
|
NIAMS
|
5P01AR052915-03
|
0003
|
Defining the Spectrum of Spondylitis in Family Members of Patients with AS
|
REVEILLE, JOHN
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$182,633
|
|
Psoriasis
|
NIAMS
|
3R01AR054966-02S1
|
|
Combined analysis of gene expression and DNA variation in psoriasis
|
ELDER, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$77,250
|
|
Psoriasis
|
NIAMS
|
5P50AR055508-02
|
0001
|
Pc4 PDT for Psoriasis
|
BARON, ELMA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$423,597
|
|
Psoriasis
|
NIAMS
|
5P50AR055508-02
|
0002
|
S100 A8/A9 and Macrophages in Psoriasis
|
COOPER, KEVIN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$423,597
|
|
Psoriasis
|
NIAMS
|
5P50AR055508-02
|
0003
|
P3:VEGF Influences Keratinocyte-Immunocyte Interactions in Psoriasiform Dermatiti
|
WARD, NICOLE
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$423,596
|
|
Psoriasis
|
NIAMS
|
5P50AR055508-02
|
9001
|
Systems Biology Core
|
KARNIK, PRATIMA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$180,020
|
|
Psoriasis
|
NIAMS
|
5P50AR055508-02
|
9002
|
Biostatistics Core
|
DIAZ-INSUA, MIREYA
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$105,887
|
|
Psoriasis
|
NIAMS
|
5P30AR053503-03
|
0005
|
Identification of Immune Targets in Psoriatic Arthritis
|
SOLOSKI, MARK
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$11,607
|
|
Psoriasis
|
NCRR
|
5M01RR000070-46
|
8019
|
CLINICAL TRIAL: RITUXIMAB WITH OR WITHOUT METHOTREX IN PSORIATIC ARTHRITIS AND P
|
GENOVESE, MARK
|
STANFORD UNIVERSITY
|
CA
|
$2,276
|
|
Psoriasis
|
NCRR
|
5M01RR006192-15
|
5329
|
GLEEVEC RESISTANCE
|
FANG, MIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$201
|
|
Psoriasis
|
NIDCR
|
5M01RR006192-15
|
5329
|
GLEEVEC RESISTANCE
|
FANG, MIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$3
|
|
Psoriasis
|
NCRR
|
2M01RR018535-06
|
5507
|
SYNOVIAL TISSUE COLLECTION
|
GULKO, PERCIO
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$34,115
|
|
Psoriasis
|
NCRR
|
5M01RR002635-24
|
5561
|
PSORIATIC ARTHRITIS AND PSORIASIS FOLLOW-UP STUDY
|
QURESHI, ABRAR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$2,189
|
|
Psoriasis
|
NCRR
|
5M01RR000051-47
|
5605
|
ROLE OF ANTIMICROBIAL PEPTIDES IN HOST DEFENSE AGAINST VACCINIA
|
LEUNG, DONALD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$2,966
|
|
Psoriasis
|
NCRR
|
5M01RR000051-47
|
5673
|
TREATMENT OF PSORIATIC ARTHRITIS WITH HOKT3Y1 (ALA-ALA)
|
STRIEBICH, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$1,028
|
|
Psoriasis
|
NCRR
|
5P20RR020145-05
|
7108
|
CHRONIC INFLAMMATION AT MUCOSAL SURFACS: INTERVENTION WITH NOVEL ANTIOXIDANTS
|
OZ, HELIEH
|
UNIVERSITY OF KENTUCKY
|
KY
|
$62,006
|
|
Psoriasis
|
NCRR
|
5P41RR001395-26
|
7231
|
CHEMICAL AND ENVIRONMENTAL EFFECTS ON MAMMALIAN SKIN
|
HECK, DIANE
|
MARINE BIOLOGICAL LABORATORY
|
MA
|
$11,282
|
|
Psoriasis
|
NCRR
|
5M01RR000827-33
|
7140
|
A MULTICENTER OPEN-LABEL CONTINUATION STUDY IN MODERATE TO SEVERE CHRONIC PLA
|
WEINSTEIN, GERALD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$69
|
|
Psoriasis
|
NIAMS
|
1Z01AR041106-14
|
|
Targeting Jak3 in the treatment of autoimmune disease
|
O'SHEA, JOHN
|
NIH
|
|
$260,338
|
